Enhancing cellular uptake of GFP via unfolded supercharged protein tags

Biomaterials

Volumn 34, Issue 17, 2013, Pages 4360-4367

  Pesce, Diego ^a   Wu, Yuzhou ^b   Kolbe, Anke ^a   Weil, Tanja ^b   Herrmann, Andreas ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

Elastin like polypeptide; Fusion protein; GFP; Protein therapeutic; Supercharged protein

Indexed keywords

ELASTIN-LIKE POLYPEPTIDES; FUSION PROTEINS; GFP; HIGH MOLECULAR WEIGHT; HYDROPHOBIC CHARACTER; LOW CYTOTOXICITIES; PHARMACOKINETIC PARAMETERS; PROTEIN THERAPEUTICS;

CYTOTOXICITY; MOLECULAR BIOLOGY; POLYPEPTIDES;

PROTEINS;

ELASTIN LIKE POLYPEPTIDE; PROTEIN; PROTEIN GFP; PROTEIN TAG; UNCLASSIFIED DRUG;

ARTICLE; BIOLOGICAL THERAPY; CAVEOLA; CELL VIABILITY; CYTOTOXICITY; DEGRADATION; ENDOCYTOSIS; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; UNFOLDED PROTEIN RESPONSE;

AMINO ACID SEQUENCE; CELL DEATH; CELL LINE, TUMOR; ELASTIN; ENDOCYTOSIS; GREEN FLUORESCENT PROTEINS; HUMANS; INTRACELLULAR SPACE; MICROSCOPY, CONFOCAL; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN UNFOLDING; RECOMBINANT FUSION PROTEINS;

MAMMALIA;

EID: 84875489613     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.02.038     Document Type: Article

References (56)

1. Overington J.P., Al-Lazikani B., Hopkins A.L. How many drug targets are there?. Nat Rev Drug Discov 2006, 5:993-996.
2. Thompson D.B., Cronican J.J., Liu D.R. Engineering and identifying supercharged proteins for macromolecule delivery into mammalian cells. Meth Enzymol 2012, 503:293-319.
3. Zelphati O., Wang Y., Kitada S., Reed J.C., Felgner P.L., Corbeil J. Intracellular delivery of proteins with a new lipid-mediated delivery system. J Biol Chem 2001, 276:35103-35110.
4. Hasadsri L., Kreuter J., Hattori H., Iwasaki T., George J.M. Functional protein delivery into neurons using polymeric nanoparticles. J Biol Chem 2009, 284:6972-6981.
5. Holm T., Johansson H., Lundberg P., Pooga M., Lindgren M., Langel ü. Studying the uptake of cell-penetrating peptides. Nat Protoc 2006, 1:1001-1005.
6. Rizk S.S., Luchniak A., Uysal S., Brawley C.M., Rock R.S., Kossiakoff A.A. An engineered substance P variant for receptor-mediated delivery of synthetic antibodies into tumor cells. Proc Natl Acad Sci U S A 2009, 106:11011-11015.
7. Heitz F., Morris M.C., Divita G. Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics. Br J Pharmacol 2009, 157:195-206.
8. Gomez J.A., Gama V., Yoshida T., Sun W., Hayes P., Leskov K., et al. Bax-inhibiting peptides derived from Ku70 and cell-penetrating pentapeptides. Biochem Soc Trans 2007, 35:797-801.
9. Shen W.C., Ryser H.J. Conjugation of poly-L-lysine to albumin and horseradish peroxidase: a novel method of enhancing the cellular uptake of proteins. Proc Natl Acad Sci U S A 1978, 75:1872-1876.
10. Chen L., Wright L.R., Chen C.H., Oliver S.F., Wender P.A., Mochly-Rosen D. Molecular transporters for peptides: delivery of a cardioprotective epsilonPKC agonist peptide into cells and intact ischemic heart using a transport system, R(7). Chem Biol 2001, 8:1123-1129.
11. Chen L., Hahn H., Wu G., Chen C.H., Liron T., Schechtman D., et al. Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC. Proc Natl Acad Sci U S A 2001, 98:11114-11119.
12. Rothbard J.B., Garlington S., Lin Q., Kirschberg T., Kreider E., McGrane P.L., et al. Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation. Nat Med 2000, 6:1253-1257.
13. Jin L.H., Bahn J.H., Eum W.S., Kwon H.Y., Jang S.H., Han K.H., et al. Transduction of human catalase mediated by an HIV-1 TAT protein basic domain and arginine-rich peptides into mammalian cells. Free Radic Biol Med 2001, 31:1509-1519.
14. Su Y., Doherty T., Waring A.J., Ruchala P., Hong M. Roles of arginine and lysine residues in the translocation of a cell-penetrating peptide from (13)C, (31)P, and (19)F solid-state NMR. Biochemistry 2009, 48:4587-4595.
15. Su Y., Li S., Hong M. Cationic membrane peptides: atomic-level insight of structure-activity relationships from solid-state NMR. Amino Acids 2012, 44:821-833.
16. Hudecz F., Gaál D., Kurucz I., Lányi á., Kovács A.L., Mezö G., et al. Carrier design: cytotoxicity and immunogenicity of synthetic branched polypeptides with poly(L-lysine) backbone. J Control Release 1992, 19:231-243.
17. Simeonov P., Berger-Hoffmann R., Hoffmann R., Sträter N., Zuchner T. Surface supercharged human enteropeptidase light chain shows improved solubility and refolding yield. Protein Eng Des Sel 2011, 24:261-268.
18. Cronican J.J., Thompson D.B., Beier K.T., McNaughton B.R., Cepko C.L., Liu D.R. Potent delivery of functional proteins into mammalian cells in vitro and in vivo using a supercharged protein. ACS Chem Biol 2010, 5:747-752.
19. Cronican J.J., Beier K.T., Davis T.N., Tseng J.-C., Li W., Thompson D.B., et al. A class of human proteins that deliver functional proteins into mammalian cells in vitro and in vivo. Chem Biol 2011, 18:833-838.
20. Lawrence M.S., Phillips K.J., Liu D.R. Supercharging proteins can impart unusual resilience. J Am Chem Soc 2007, 129:10110-10112.
21. Kolbe A., del Mercato L.L., Abbasi A.Z., Rivera Gil P., Gorzini S.J., Huibers W.H.C., et al. De novo design of supercharged, unfolded protein polymers, and their assembly into supramolecular aggregates. Macromol Rapid Commun 2010, 32:186-190.
22. Nettles D.L., Chilkoti A., Setton L.A. Applications of elastin-like polypeptides in tissue engineering. Adv Drug Deliv Rev 2010, 62:1479-1485.
23. Megeed Z., Haider M., Li D., O'Malley B.W., Cappello J., Ghandehari H. In vitro and in vivo evaluation of recombinant silk-elastin like hydrogels for cancer gene therapy. J Control Release 2004, 94:433-445.
24. Dandu R., Ghandehari H. Delivery of bioactive agents from recombinant polymers. Prog Polym Sci 2007, 32:1008-1030.
25. MacEwan S.R., Chilkoti A. Elastin-like polypeptides: biomedical applications of tunable biopolymers. Biopolymers 2010, 94:60-77.
26. Bidwell G.L., Raucher D. Cell penetrating elastin-like polypeptides for therapeutic peptide delivery. Adv Drug Deliv Rev 2010, 62:1486-1496.
27. Na K., Lee S.A., Jung S.H., Hyun J., Shin B.C. Elastin-like polypeptide modified liposomes for enhancing cellular uptake into tumor cells. Colloids Surf B 2012, 91:130-136.
28. Meyer D., Chilkoti A. Genetically encoded synthesis of protein-based polymers with precisely specified molecular weight and sequence by recursive directional ligation: examples from the elastin-like polypeptide system. Biomacromolecules 2002, 3:357-367.
29. Ren Y., Wong S.M., Lim L.-Y. Folic acid-conjugated protein cages of a plant virus: a novel delivery platform for doxorubicin. Bioconjug Chem 2007, 18:836-843.
30. Liu S.Q., Tong Y.W., Yang Y.-Y. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N, N-dimethylacrylamide)-b-poly(D, L-lactide-co-glycolide) with varying compositions. Biomaterials 2005, 26:5064-5074.
31. Lacerda L., Russier J., Pastorin G., Herrero M.A., Venturelli E., Dumortier H., et al. Translocation mechanisms of chemically functionalised carbon nanotubes across plasma membranes. Biomaterials 2012, 33:3334-3343.
32. Zelikin A.N., Breheney K., Robert R., Tjipto E., Wark K. Cytotoxicity and internalization of polymer hydrogel capsules by mammalian cells. Biomacromolecules 2010, 11:2123-2129.
33. Perumal O.P., Inapagolla R., Kannan S., Kannan R.M. The effect of surface functionality on cellular trafficking of dendrimers. Biomaterials 2008, 29:3469-3476.
34. Puri V., Watanabe R., Singh R.D., Dominguez M., Brown J.C., Wheatley C.L., et al. Clathrin-dependent and -independent internalization of plasma membrane sphingolipids initiates two Golgi targeting pathways. J Cell Biol 2001, 154:535-547.
35. Lin R., Shi Ng L., Wang C.-H. In vitro study of anticancer drug doxorubicin in PLGA-based microparticles. Biomaterials 2005, 26:4476-4485.
36. Massodi I., Moktan S., Rawat A., Bidwell G.L., Raucher D. Inhibition of ovarian cancer cell proliferation by a cell cycle inhibitory peptide fused to a thermally responsive polypeptide carrier. Int J Cancer 2010, 126:533-544.
37. Shamji M.F., Chen J., Friedman A.H., Richardson W.J., Chilkoti A., Setton L.A. Synthesis and characterization of a thermally-responsive tumor necrosis factor antagonist. J Control Release 2008, 129:179-186.
38. Thompson D.B., Villaseñor R., Dorr B.M., Zerial M., Liu D.R. Cellular uptake mechanisms and endosomal trafficking of supercharged proteins. Chem Biol 2012, 19:831-843.
39. Godbey W.T., Wu K.K., Mikos A.G. Tracking the intracellular path of poly (ethylenimine)/DNA complexes for gene delivery. Proc Natl Acad Sci U S A 1999, 96:5177-5181.
40. Beyerle A., Merkel O., Stoeger T., Kissel T. PEGylation affects cytotoxicity and cell-compatibility of poly(ethylene imine) for lung application: structure-function relationships. Toxicol Appl Pharmacol 2010, 242:146-154.
41. Jones S.W., Christison R., Bundell K., Voyce C.J., Brockbank S.M.V., Newham P., et al. Characterisation of cell-penetrating peptide-mediated peptide delivery. Br J Pharmacol 2005, 145:1093-1102.
42. Leroueil P.R., Hong S., Mecke A., Baker J.R., Orr B.G., Banaszak Holl M.M. Nanoparticle interaction with biological membranes: does nanotechnology present a Janus face?. Acc Chem Res 2007, 40:335-342.
43. Choi Y.H., Liu F., Park J.S., Kim S.W. Lactose-poly(ethylene glycol)-grafted poly-L-lysine as hepatoma cell-targeted gene carrier. Bioconjug Chem 1998, 9:708-718.
44. Lee H., Jeong J.H., Park T.G. PEG grafted polylysine with fusogenic peptide for gene delivery: high transfection efficiency with low cytotoxicity. J Control Release 2002, 79:283-291.
45. Choksakulnimitr S., Masuda S., Tokuda H., Takakura Y., Hashida M. In vitro cytotoxicity of macromolecules in different cell culture systems. J Control Release 1995, 34:233-241.
46. Eisele K., Gropeanu R.A., Zehendner C.M., Rouhanipour A., Ramanathan A., Mihov G., et al. Fine-tuning DNA/albumin polyelectrolyte interactions to produce the efficient transfection agent cBSA-147. Biomaterials 2010, 31:8789-8801.
47. Canton I., Battaglia G. Endocytosis at the nanoscale. Chem Soc Rev 2012, 41:2718-2739.
48. Schnitzer J.E., Oh P., Pinney E., Allard J. Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules. J Cell Biol 1994, 127:1217-1232.
49. Wang L.H., Rothberg K.G., Anderson R.G. Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation. J Cell Biol 1993, 123:1107-1117.
50. Rejman J., Oberle V., Zuhorn I.S., Hoekstra D. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem J 2004, 377:159-169.
51. Shin J.S., Abraham S.N. Caveolae as portals of entry for microbes. Microb Infect 2001, 3:755-761.
52. Wadia J.S., Stan R.V., Dowdy S.F. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat Med 2004, 10:310-315.
53. Nakase I., Tadokoro A., Kawabata N., Takeuchi T., Katoh H., Hiramoto K., et al. Interaction of arginine-rich peptides with membrane-associated proteoglycans is crucial for induction of actin organization and macropinocytosis. Biochemistry 2007, 46:492-501.
54. Guterstam P., Madani F., Hirose H., Takeuchi T., Futaki S., Andaloussi El S., et al. Elucidating cell-penetrating peptide mechanisms of action for membrane interaction, cellular uptake, and translocation utilizing the hydrophobic counter-anion pyrenebutyrate. Biochim Biophys Acta 2009, 1788:2509-2517.
55. Säälik P., Elmquist A., Hansen M., Padari K., Saar K., Viht K., et al. Protein cargo delivery properties of cell-penetrating peptides. A comparative study. Bioconjug Chem 2004, 15:1246-1253.
56. Richard J.P., Melikov K., Brooks H., Prevot P., Lebleu B., Chernomordik L.V. Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors. J Biol Chem 2005, 280:15300-15306.